Business Today
Subscribe
IndiaNRICareer & JobsUS NewsWeatherPetrol PricesDiesel PricesPMS TodayBT Reels
EY Business Today Hidden Gems 2026BT MindrushBT India 100
Search
Advertisement
Business News
markets
stocks
Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd

Goldline Pharmaceutical Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 51,000
Jun 19, 2026
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹42.98
₹-0.69 (-1.58%)
42.67Low
Today’s Performance
43.55High
41.41Low
52 Week’s Performance
60.00High

bt_logoStock Performance

  • 1 Day-1.58%
  • 1 Week-7.67%
  • 1 Month-24.29%
  • 3 Months-%
  • 6 Months-%
  • 1 Year-%
  • 3 Years-%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta-1.30
  • 52-Week Low (₹)41.41
  • 52-Week High (₹)60.00
  • Price-to-Book (X)*2.05
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-
  • Market Cap (₹ Cr.)*41.26
* Values as of last close price

bt_logoCOMPETITORS

BT TV

How Ashishkumar Chauhan Revived NSE & Cleared The IPO Path23:22How Ashishkumar Chauhan Revived NSE & Cleared The IPO Path
Software Stocks Fell Sharply On Accenture's Guidance Cut; Nifty Slips4:58Software Stocks Fell Sharply On Accenture's Guidance Cut; Nifty Slips
"Fast-Track Growth": SEBI Launches GARUDA For AIFs And Aligns SDI Rules With RBI Standards5:33"Fast-Track Growth": SEBI Launches GARUDA For AIFs And Aligns SDI Rules With RBI Standards
Indian IT Stocks Crash To Multi-Year Lows Following Accenture’s Weak Revenue Guidance3:05Indian IT Stocks Crash To Multi-Year Lows Following Accenture’s Weak Revenue Guidance
Reliance Industries Stock Falls: Is RIL A Buy Low Opportunity Or A Value Trap?3:04Reliance Industries Stock Falls: Is RIL A Buy Low Opportunity Or A Value Trap?
Ayodhya Donation Probe: Nripendra Misra Demands Full Transparency As SIT Investigation Intensifies11:23Ayodhya Donation Probe: Nripendra Misra Demands Full Transparency As SIT Investigation Intensifies
SEBI Simplifies Securities Transmission And Revives Open-Market Buybacks From August 1, 20267:03SEBI Simplifies Securities Transmission And Revives Open-Market Buybacks From August 1, 2026
Delhi High Court Upholds Telegram Ban To Ensure Integrity Of NEET-UG Re-Test3:14Delhi High Court Upholds Telegram Ban To Ensure Integrity Of NEET-UG Re-Test
Lower Crude Oil Prices Could Boost Indian Stock Market: Dalal Street Outlook Explained1:56Lower Crude Oil Prices Could Boost Indian Stock Market: Dalal Street Outlook Explained
MobiKwik Targets ₹5,000 Crore Lending Disbursals, Aims To Double Profitability In FY273:34MobiKwik Targets ₹5,000 Crore Lending Disbursals, Aims To Double Profitability In FY27
View more

bt_logoFAQs

What was Goldline Pharmaceutical Ltd share price previously?
Goldline Pharmaceutical Ltd share price was down by -1.58% from the previous closing price of ₹43.67.
Who are peers of Goldline Pharmaceutical Ltd?
The peers of Goldline Pharmaceutical Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Lupin Ltd, Dr Reddys Laboratories Ltd.
Who is/are the promoter/promoters of Goldline Pharmaceutical Ltd?
The promotor/promotors of Goldline Pharmaceutical Ltd are AMOL LAXMIKANT MUJUMDAR, Swapan Prernprakash Khandelwal, Prashant Shriknshna Karkare, Avinash Pandurang Ambulkar, Prashant Vithal Rahate, Mehul Hari Ranade, Renuka Saurabh Borole, Shraddha Kiran Kulkarni, Ruchi Sanket Modi.
What has been 52-week high of Goldline Pharmaceutical Ltd stocks?
The highest price of Goldline Pharmaceutical Ltd stock is ₹60.00 in the last 52-week.
What is the share price of Goldline Pharmaceutical Ltd (GLPL) today on BSE?
As on Jun 19, 2026 Goldline Pharmaceutical Ltd (GLPL)’s share price on BSE is Rs 42.98
What is the market cap of Goldline Pharmaceutical Ltd (GLPL)?
The current market capitalisation of Goldline Pharmaceutical Ltd (GLPL) is 41.26 crores
What is Goldline Pharmaceutical Ltd Share symbol?
The symbol of Goldline Pharmaceutical Ltd is .
What is the PE ratio of Goldline Pharmaceutical Ltd (GLPL)?
The current PE ratio of Goldline Pharmaceutical Ltd (GLPL) is -.
What is the PB ratio of Goldline Pharmaceutical Ltd (GLPL)?
The current PB ratio of Goldline Pharmaceutical Ltd (GLPL) is 2.05.
Today’s High & Low share prices of Goldline Pharmaceutical Ltd (GLPL) on BSE?
Today, the share price of Goldline Pharmaceutical Ltd (GLPL) on BSE touched a high of Rs 43.55 and a low of Rs 42.67
What price did Goldline Pharmaceutical Ltd (GLPL) shares open on the BSE today?
On BSE, the share price of Goldline Pharmaceutical Ltd (GLPL) opened at Rs 43.16
What is the 52-week high of Goldline Pharmaceutical Ltd (GLPL)?
The 52-week high price of Goldline Pharmaceutical Ltd (GLPL) is Rs 60.00
What is the 52-week low of Goldline Pharmaceutical Ltd (GLPL)?
The 52-week low price of Goldline Pharmaceutical Ltd (GLPL) is Rs 41.41

bt_logoAbout Goldline Pharmaceutical

Goldline Pharmaceutical Ltd, incorporated in the year 2004, has its registered office in 103 F-1 Leela Apartment Shilpa, HSG Society Shanidham Narendra, Nagpur, Maharashtra, 440015, +91 712 278 6666. The main industry in which Goldline Pharmaceutical Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Goldline Pharmaceutical Ltd is/are . In the main management, AMOL LAXMIKANT MUJUMDAR is chairman and Ruchi Sanket Modi is the company secretary for Goldline Pharmaceutical Ltd.

  • ALM
    AMOL LAXMIKANT MUJUMDARChairman / Executive Director / M D / Promoter
  • SPK
    Swapan Prernprakash KhandelwalWTD & Executive Director
  • PSK
    Prashant Shriknshna KarkareExecutive Director
  • APA
    Avinash Pandurang AmbulkarExecutive Director
  • PVR
    Prashant Vithal RahateNon Executive Director
  • MHR
    Mehul Hari RanadeIndependent Non Exe. Director
  • RSB
    Renuka Saurabh BoroleIndependent Non Exe. Director
  • SKK
    Shraddha Kiran KulkarniIndependent Non Exe. Director
  • RSM
    Ruchi Sanket ModiCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.